Vitiligo can go away on its own in some cases, but it frequently comes back. About one in five people with vitiligo experience some degree of spontaneous repigmentation without any treatment, though complete repigmentation is rare, occurring in only about 4% of patients. Even when pigment returns, whether naturally or through treatment, the risk of relapse is estimated at 40% within the first year. Understanding why this happens and what influences it can help you know what to expect.
How Pigment Returns on Its Own
Spontaneous repigmentation, where white patches regain color without medical intervention, happens more often than most people realize. In a cross-sectional study of vitiligo patients, 21.5% showed some spontaneous return of pigment. But “some” is the key word. Only 3.6% achieved complete repigmentation on their own. In most cases, the color that returns is partial, appearing as small dots or islands of pigment within the white patch rather than a full restoration.
This repigmentation typically comes from melanocytes (pigment-producing cells) that survived in hair follicles within the affected skin. These cells can migrate outward and begin producing pigment again, which is why returning color often appears first as small spots around hair follicles. Areas with dense hair follicles, like the face, tend to repigment more successfully than areas with fewer follicles, like the hands and feet.
Why It Comes Back to the Same Spots
One of the most frustrating aspects of vitiligo is that when it returns, it often reappears in the exact same locations. This isn’t random. Your immune system stations specialized cells in the skin called resident memory T cells. These cells form during active vitiligo and remain embedded in previously affected skin long after the white patches have faded. They essentially act as sentinels, lying dormant but ready to reactivate.
When treatment is stopped or a trigger occurs, these resident memory cells can quickly mount a new attack against melanocytes in that same patch of skin. They upregulate specific surface markers that keep them anchored in the tissue rather than circulating through the bloodstream, which is why they persist locally for months or years. This is the core reason depigmentation typically recurs rapidly at the same location after therapy is stopped.
Segmental vs. Non-Segmental Vitiligo
The type of vitiligo you have significantly affects whether pigment loss is likely to return. Segmental vitiligo, which affects only one side or area of the body, behaves very differently from non-segmental vitiligo, the more common form that appears symmetrically on both sides.
Segmental vitiligo tends to stabilize over time. Once it has been stable for at least two years, it is five times less likely to reactivate compared to disease that has been stable for less than two years. Among patients with segmental vitiligo who maintained stability for over two years, only about 31% experienced reactivation. For those stable for less than two years, reactivation was as high as 73%.
Non-segmental vitiligo tells a very different story. Reactivation was seen in 80 to 100% of patients regardless of how long the disease had been stable. Researchers could not identify any duration of stability in non-segmental vitiligo beyond which reactivation became unlikely. If you have the non-segmental type, the reality is that some degree of recurrence is probable over the long term, even after years of quiet disease.
What Triggers a Relapse
Several factors can wake up dormant vitiligo or accelerate its return. These triggers work by generating oxidative stress in melanocytes or by activating immune responses that target pigment cells.
- Skin trauma: Cuts, burns, friction, and even sunburns can trigger depigmentation in a new or previously affected area. This is known as the Koebner phenomenon, where injury to the skin provokes a vitiligo response.
- Chemical exposure: Certain chemicals generate free radicals and hydrogen peroxide in the skin, which in people predisposed to vitiligo leads to an immune activation against melanocytes.
- Sunburn: While controlled UV exposure is used therapeutically, unprotected sun exposure that causes burning can trigger or worsen patches.
- Psychological stress: Major life events like the death of a family member, financial problems, or work-related stress have been associated with both the initial onset and the progression of vitiligo. The connection between stress and flare-ups is well documented, though the exact pathway involves complex interactions between the nervous and immune systems.
Not every trigger will cause a relapse in every person. But if you’ve noticed a pattern between certain events and changes in your skin, that pattern is likely real.
How Long Treatment Results Last
The durability of repigmentation depends on the treatment method, the body area treated, and whether you continue some form of maintenance after achieving results.
Narrowband UVB phototherapy, one of the most common treatments, produces surprisingly durable results for many patients. In a retrospective study of patients who achieved clinically significant repigmentation, 95% maintained their results for at least six months after stopping treatment. More impressively, 59% sustained their repigmentation for over six years. The face and neck region responded best, with a 53% success rate for clinically significant improvement. These numbers suggest that for a meaningful subset of patients, phototherapy-induced repigmentation can be long-lasting.
For topical treatments like JAK inhibitors (the class that includes the FDA-approved cream for vitiligo), available data on relapse is more limited. Case reports suggest relapse can occur after an average of about nine months following drug withdrawal, though larger studies are still needed to define long-term durability.
Preventing Recurrence After Treatment
Because resident memory immune cells persist in the skin, simply stopping treatment after repigmentation leaves those cells free to reactivate. This is why dermatologists increasingly discuss proactive maintenance therapy: continuing a low-frequency application of topical medication to areas that have responded to treatment, even after the skin looks normal.
One approach studied involves applying a topical calcineurin inhibitor to previously affected areas on a reduced schedule after repigmentation is achieved. In a randomized trial, areas treated with maintenance therapy showed depigmentation in only about 10% of lesions, compared to 40% in the group that stopped treatment entirely. The idea is to keep the immune memory cells suppressed without requiring full daily treatment indefinitely.
There is not yet a universal consensus on exactly how long maintenance should continue or how often the medication should be applied. Practice varies by dermatologist and depends on your specific pattern of disease, which areas are involved, and how aggressive your vitiligo has been historically. What is clear is that some form of ongoing, intermittent treatment significantly reduces the chance of losing hard-won pigment.
What This Means in Practical Terms
If your vitiligo patches have faded or repigmented, that is a genuinely positive sign, but it does not mean the underlying process is gone. The immune memory that caused the original patches persists in your skin. For people with non-segmental vitiligo, recurrence at some point is more the rule than the exception. For segmental vitiligo, two or more years of stability is a meaningful milestone that significantly lowers your risk going forward.
The most useful thing you can do is pay attention to the triggers that affect your skin, protect healing areas from trauma and sunburn, manage stress where possible, and discuss maintenance strategies with your dermatologist if you’ve achieved repigmentation through treatment. Vitiligo is a chronic condition, but its course is not entirely unpredictable. Knowing the patterns gives you more control over what happens next.